Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (552)	5/16/2000 10:16:00 AM
From: D.Lu	Read Replies (1) \| Respond to of 1475

This is extremely good news. What kind of primate do you suppose is involved?

To: scaram(o)uche who wrote (552)	5/16/2000 3:54:00 PM
From: biowa	Read Replies (1) \| Respond to of 1475

Be careful, someone's listening... TUE May 16, 00, 1:33 PM CHARLESTOWN, Mass., May 16 /PRNewswire/ -- BioTransplant Incorporated (Nasdaq: BTRN) and its collaborators from the Transplantation Unit and the Transplantation Biology Research Center (TRBC) of the Massachusetts General Hospital (MGH) today announced the successful transplantation of primate pancreatic islet cells into a mismatched diabetic primate without the need for long-term administration of immunosuppressive drugs.